RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Return
24.59%
This Quarter Return
-3.06%
1 Year Return
+24.59%
3 Year Return
+106.81%
5 Year Return
+195.15%
10 Year Return
+469.64%
AUM
$77.7B
AUM Growth
-$3.9B
(-4.8%)
Cap. Flow
+$517M
Cap. Flow
% of AUM
0.67%
Top 10 Holdings %
Top 10 Hldgs %
24.09%
Holding
3,066
New
55
Increased
1,482
Reduced
1,461
Closed
51
Top Buys
| 1 |
Advanced Micro Devices
AMD
|
$76.4M |
| 2 |
S&P Global
SPGI
|
$74M |
| 3 |
Tesla
TSLA
|
$64.3M |
| 4 |
Microsoft
MSFT
|
$47M |
| 5 |
Constellation Energy
CEG
|
$29.7M |
Top Sells
| 1 |
XLNX
Xilinx Inc
XLNX
|
$88.8M |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
$74.7M |
| 3 |
CONE
CyrusOne Inc Common Stock
CONE
|
$31.7M |
| 4 |
Exelon
EXC
|
$26.1M |
| 5 |
Abbott
ABT
|
$24.4M |
Sector Composition
| 1 | Technology | 24.75% |
| 2 | Financials | 13.53% |
| 3 | Healthcare | 13.01% |
| 4 | Consumer Discretionary | 11.66% |
| 5 | Industrials | 8.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2926
Team
TISI
$86.5M
| $81K | ﹤0.01% |
3,655
-335
| -8% | -$7.42K |
|
2927
AgEagle Aerial Systems
UAVS
$60.2M
| $80K | ﹤0.01% |
67
-3
| -4% | -$3.58K |
|
2928
Wave Life Sciences
WVE
$1.3B
| $80K | ﹤0.01% |
40,249
+2,566
| +7% | +$5.1K |
|
2929
Acumen Pharmaceuticals
ABOS
$83.6M
| $79K | ﹤0.01% |
+20,273
| New | +$79K |
|
2930
NL Industries
NL
$324M
| $79K | ﹤0.01% |
10,981
-1,370
| -11% | -$9.86K |
|
|
TRVN
2931
DELISTED
Trevena, Inc.
TRVN
| $79K | ﹤0.01% |
231
-15
| -6% | -$5.13K |
|
|
SMED
2932
DELISTED
Sharps Compliance Corp
SMED
| $79K | ﹤0.01% |
+13,335
| New | +$79K |
|
2933
Neurogene
NGNE
$280M
| $78K | ﹤0.01% |
2,073
-164
| -7% | -$6.17K |
|
|
SRT
2934
DELISTED
Startek Inc.
SRT
| $78K | ﹤0.01% |
17,716
-538
| -3% | -$2.37K |
|
|
AMPE
2935
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $77K | ﹤0.01% |
548
+62
| +13% | +$8.71K |
|
|
SYRS
2936
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $76K | ﹤0.01% |
6,387
-279
| -4% | -$3.32K |
|
2937
GoHealth
GOCO
$78.2M
| $74K | ﹤0.01% |
4,164
-224
| -5% | -$3.98K |
|
2938
BioAtla
BCAB
$29.3M
| $73K | ﹤0.01% |
14,549
+2,336
| +19% | +$11.7K |
|
2939
Dianthus Therapeutics
DNTH
$794M
| $73K | ﹤0.01% |
1,564
+28
| +2% | +$1.31K |
|
2940
Retractable Technologies
RVP
$23.4M
| $73K | ﹤0.01% |
15,372
+2,230
| +17% | +$10.6K |
|
|
ONCT
2941
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $73K | ﹤0.01% |
2,616
-134
| -5% | -$3.74K |
|
2942
Mustang Bio
MBIO
$10.6M
| $72K | ﹤0.01% |
95
-12
| -11% | -$9.1K |
|
2943
Rapid Micro Biosystems
RPID
$108M
| $72K | ﹤0.01% |
+10,611
| New | +$72K |
|
|
NBEV
2944
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
| $72K | ﹤0.01% |
124,186
-2,353
| -2% | -$1.36K |
|
|
AWH
2945
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
| $70K | ﹤0.01% |
4,473
-6
| -0.1% | -$94 |
|
|
PPTA
2946
Perpetua Resources
PPTA
$1.94B
| $69K | ﹤0.01% |
16,811
+2,456
| +17% | +$10.1K |
|
2947
Prelude Therapeutics
PRLD
$64.5M
| $69K | ﹤0.01% |
+10,050
| New | +$69K |
|
2948
Clene
CLNN
$59.4M
| $67K | ﹤0.01% |
846
+98
| +13% | +$7.76K |
|
2949
MEI Pharma
MEIP
$140M
| $66K | ﹤0.01% |
5,493
+510
| +10% | +$6.13K |
|
|
IVC
2950
DELISTED
Invacare Corporation
IVC
| $66K | ﹤0.01% |
46,921
-4,810
| -9% | -$6.77K |
|